SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-052729
Filing Date
2023-11-13
Accepted
2023-11-13 07:50:51
Documents
59
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20012440_10q.htm   iXBRL 10-Q 1124158
2 EXHIBIT 31.1 ef20012440_ex31-1.htm EX-31.1 11676
3 EXHIBIT 31.2 ef20012440_ex31-2.htm EX-31.2 11769
4 EXHIBIT 32.1 ef20012440_ex32-1.htm EX-32.1 5573
5 EXHIBIT 32.2 ef20012440_ex32-2.htm EX-32.2 5658
  Complete submission text file 0001140361-23-052729.txt   5734698

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20230930.xsd EX-101.SCH 43741
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20230930_cal.xml EX-101.CAL 34093
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20230930_def.xml EX-101.DEF 238997
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20230930_lab.xml EX-101.LAB 588464
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20230930_pre.xml EX-101.PRE 370717
53 EXTRACTED XBRL INSTANCE DOCUMENT ef20012440_10q_htm.xml XML 780582
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 231395177
SIC: 2834 Pharmaceutical Preparations